Clinical Trials Directory

Trials / Completed

CompletedNCT00699946

Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery

A Double-Blind, Randomized, Placebo-Controlled Study of Perioperative Administration of Olanzapine to Prevent Postoperative Delirium in Joint Replacement Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
495 (actual)
Sponsor
The New England Baptist Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

In this study we wanted to determine if perioperative administration of olanzapine prior to knee or hip replacement surgery in high risk patients would prevent the onset of postoperative delirium.

Detailed description

Postoperative delirium is a serious and common (20% to 60%) complication in orthopedic surgery patients. In this study we investigate whether prophylactic administration of olanzapine can prevent delirium from occurring after knee or hip replacement in high-risk patients \> 65 years of age. This is a randomized, double-blind, single center, placebo-controlled study.

Conditions

Interventions

TypeNameDescription
DRUGolanzapine5 mg preoperative and 5mg postoperative prior to discharge to inpatient nursing floor
DRUGplaceboplacebo administered preoperatively and postoperatively prior to discharge to inpatient nursing floor

Timeline

Start date
2005-01-01
Primary completion
2007-08-01
Completion
2007-10-01
First posted
2008-06-18
Last updated
2009-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00699946. Inclusion in this directory is not an endorsement.